| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 6 | 2021 | 205 | 0.760 |
Why?
|
| Blood Group Incompatibility | 2 | 2018 | 27 | 0.730 |
Why?
|
| ABO Blood-Group System | 2 | 2018 | 66 | 0.720 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 1201 | 0.690 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 29 | 0.590 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2016 | 106 | 0.580 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 167 | 0.560 |
Why?
|
| Mutation | 8 | 2024 | 5848 | 0.540 |
Why?
|
| Rare Diseases | 3 | 2017 | 191 | 0.500 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1036 | 0.480 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 66 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 3156 | 0.430 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 250 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 711 | 0.300 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 20 | 0.290 |
Why?
|
| Heterozygote | 2 | 2022 | 671 | 0.290 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 146 | 0.280 |
Why?
|
| Protein Subunits | 1 | 2018 | 165 | 0.280 |
Why?
|
| Infant | 17 | 2023 | 12476 | 0.270 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 149 | 0.260 |
Why?
|
| Child, Preschool | 16 | 2024 | 14005 | 0.260 |
Why?
|
| Genome, Human | 2 | 2018 | 1274 | 0.260 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 130 | 0.260 |
Why?
|
| Child | 22 | 2023 | 24384 | 0.250 |
Why?
|
| Coatomer Protein | 2 | 2016 | 30 | 0.250 |
Why?
|
| Syndrome | 4 | 2023 | 1120 | 0.250 |
Why?
|
| Exome | 3 | 2022 | 1033 | 0.240 |
Why?
|
| Virus Diseases | 2 | 2019 | 280 | 0.240 |
Why?
|
| Alleles | 2 | 2018 | 1616 | 0.230 |
Why?
|
| Humans | 43 | 2024 | 125086 | 0.230 |
Why?
|
| Infant, Newborn | 9 | 2022 | 8202 | 0.220 |
Why?
|
| Ikaros Transcription Factor | 1 | 2023 | 28 | 0.210 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 48 | 0.200 |
Why?
|
| Male | 22 | 2024 | 61463 | 0.200 |
Why?
|
| Software | 1 | 2017 | 683 | 0.200 |
Why?
|
| Replication Protein A | 1 | 2022 | 11 | 0.190 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 30 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2017 | 1501 | 0.190 |
Why?
|
| Hearing Loss | 1 | 2023 | 135 | 0.190 |
Why?
|
| Telomere Shortening | 1 | 2022 | 33 | 0.190 |
Why?
|
| Interferon Type I | 2 | 2021 | 107 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 558 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2023 | 240 | 0.180 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 10 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 503 | 0.180 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 106 | 0.180 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 10 | 0.180 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 40 | 0.180 |
Why?
|
| I-kappa B Kinase | 2 | 2022 | 61 | 0.170 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 140 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 142 | 0.170 |
Why?
|
| Telomere | 1 | 2022 | 213 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2021 | 155 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 829 | 0.170 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 120 | 0.170 |
Why?
|
| Female | 21 | 2022 | 66747 | 0.170 |
Why?
|
| Anaphylaxis | 1 | 2021 | 81 | 0.160 |
Why?
|
| Base Sequence | 2 | 2018 | 3102 | 0.160 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 175 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2023 | 589 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 331 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1056 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 185 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1758 | 0.150 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2019 | 59 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 61 | 0.150 |
Why?
|
| Phenotype | 4 | 2018 | 4260 | 0.150 |
Why?
|
| Arthritis | 2 | 2016 | 80 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2018 | 114 | 0.140 |
Why?
|
| Alemtuzumab | 1 | 2018 | 88 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 23 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 546 | 0.140 |
Why?
|
| Chromatin | 1 | 2021 | 554 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 651 | 0.140 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 180 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2018 | 330 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2019 | 300 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 47 | 0.140 |
Why?
|
| Metapneumovirus | 1 | 2017 | 51 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 239 | 0.140 |
Why?
|
| Adolescent | 13 | 2022 | 19351 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2019 | 167 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 797 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 399 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 512 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 263 | 0.140 |
Why?
|
| Cell Line | 2 | 2021 | 2757 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3071 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2016 | 2588 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 390 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 779 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 860 | 0.130 |
Why?
|
| Young Adult | 9 | 2023 | 9052 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 153 | 0.130 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2022 | 525 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 548 | 0.130 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 28 | 0.130 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 324 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 881 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 798 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2016 | 120 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2019 | 172 | 0.120 |
Why?
|
| Enteritis | 1 | 2016 | 54 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2021 | 414 | 0.120 |
Why?
|
| Family | 1 | 2018 | 567 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 93 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1169 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5175 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 1727 | 0.110 |
Why?
|
| Inflammation | 2 | 2019 | 1444 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2820 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 181 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 149 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2024 | 12391 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2014 | 130 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 328 | 0.100 |
Why?
|
| Cytokines | 2 | 2021 | 1288 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 134 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 330 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2018 | 1002 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2024 | 173 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 79 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 220 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 294 | 0.090 |
Why?
|
| Adult | 9 | 2023 | 29632 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 126 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2023 | 16326 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 330 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 2717 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 2008 | 35 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2008 | 53 | 0.070 |
Why?
|
| Genitalia | 1 | 2016 | 35 | 0.070 |
Why?
|
| Biopsy | 2 | 2023 | 1236 | 0.070 |
Why?
|
| Genotype | 2 | 2017 | 2561 | 0.070 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 149 | 0.070 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 103 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2016 | 43 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 133 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2016 | 119 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 281 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 736 | 0.060 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 187 | 0.060 |
Why?
|
| Education, Professional | 1 | 2005 | 10 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 33 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2016 | 255 | 0.060 |
Why?
|
| Ataxia | 1 | 2016 | 170 | 0.060 |
Why?
|
| Cross Infection | 1 | 2008 | 325 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2017 | 186 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2017 | 474 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1895 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2017 | 539 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2019 | 383 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1214 | 0.050 |
Why?
|
| Metabolomics | 1 | 2017 | 423 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 45 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 21 | 0.050 |
Why?
|
| Mitochondria | 1 | 2018 | 682 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 51 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 40 | 0.050 |
Why?
|
| Survival Rate | 2 | 2017 | 2061 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2022 | 109 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 15 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 396 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 417 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 960 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 504 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 258 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 313 | 0.040 |
Why?
|
| Genomics | 2 | 2018 | 1502 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 216 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 634 | 0.040 |
Why?
|
| Middle Aged | 4 | 2022 | 26926 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 534 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 41 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 318 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 359 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 788 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 82 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 37 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 50 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 69 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 139 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 191 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 540 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 206 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 480 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 706 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 58 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 328 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 4814 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 899 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 293 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 99 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 120 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 506 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2047 | 0.030 |
Why?
|
| Incidence | 2 | 2018 | 3140 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 762 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 683 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 217 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 385 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 368 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 443 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2452 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 1 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1054 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 12 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 50 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6154 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1357 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 542 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 479 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4638 | 0.020 |
Why?
|
| United States | 1 | 2017 | 10912 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1604 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 950 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 294 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1064 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1684 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 504 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 663 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1103 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 1149 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3892 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1290 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2817 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2633 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 16 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 19 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 53 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 155 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2426 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 133 | 0.020 |
Why?
|
| Infection Control | 1 | 2008 | 155 | 0.020 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 1 | 0.020 |
Why?
|
| International Agencies | 1 | 2005 | 29 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1584 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2005 | 150 | 0.010 |
Why?
|
| Schools | 1 | 2005 | 218 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10284 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 760 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2003 | 93 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 70 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 262 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4531 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 726 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 19861 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1065 | 0.010 |
Why?
|